The pharmaceutical industry's 'wonder drug'

被引：0

|

作者：

Silverman, WA

机构：

来源：

PAEDIATRIC AND PERINATAL EPIDEMIOLOGY | 2004年 / 18卷 / 06期

关键词：

D O I：

10.1111/j.1365-3016.2004.00551.x

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

收藏

页码：398 / 399

页数：2

相关论文

共 50 条

[31] Is the pharmaceutical industry’s preoccupation with the monotherapy drug model stifling the development of effective new drug therapies?
Ian Edwin Cock
[J]. Inflammopharmacology, 2018, 26 : 861 - 879
[32] Wonder drug
Dolan, Kerry A.
[J]. FORBES, 2006, 178 (02): : 178 - 178
[33] No wonder drug
Moss, Ralph
[J]. NEW SCIENTIST, 2007, 193 (2589) : 20 - 20
[34] THE WONDER DRUG
Bruenig, Elizabeth
[J]. NEW REPUBLIC, 2015, 246 (12) : 19 - 25
[35] Barriers to Alzheimer disease drug discovery and drug development in the pharmaceutical industry
Anand, R
[J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2002, 16 : S33 - S39
[36] New drug innovation and pharmaceutical industry structure: Trends in the output of pharmaceutical firms
DiMasi, JA
[J]. DRUG INFORMATION JOURNAL, 2000, 34 (04): : 1169 - 1194
[37] New Drug Innovation and Pharmaceutical Industry Structure: Trends in the Output of Pharmaceutical Firms
Joseph A. DiMasi
[J]. Drug information journal : DIJ / Drug Information Association, 2000, 34 (4): : 1169 - 1194
[38] PROSPECTS OF CHINA'S PHARMACEUTICAL INDUSTRY
Staff reporterJiang Min
[J]. China's Foreign Trade, 1996, (04) : 18 - 18
[39] Restoring the pharmaceutical industry's reputation
Mark Kessel
[J]. Nature Biotechnology, 2014, 32 : 983 - 990
[40] On the design of complex drug candidate syntheses in the pharmaceutical industry
Eastgate, Martin D.
Schmidt, Michael A.
Fandrick, Keith R.
[J]. NATURE REVIEWS CHEMISTRY, 2017, 1 (02)

← 1 2 3 4 5 →